{
  "case_id": "case_0002",
  "provider": "openai",
  "status": "processed",
  "patient_demographics": {
    "age": 27.61,
    "sex": "Female",
    "genderIdentity": "Non-binary",
    "ancestry": "European"
  },
  "marking_output": {
    "Localisation": {
      "report_string": "--- Localisation ---\nAgree with lesions involving:\n- right cerebellum and left optic nerve (cranial nerve II).\n  \nRemaining signs are better explained by:\n- right T7 spinal cord lesion\n\nThan the suggested:\n- left paracentral lobule.",
      "structured_data": {
        "gt_lesions_english": [
          "right T7 myelopathy",
          "right cerebellum",
          "left optic nerve (cranial nerve II)"
        ],
        "ft_lesions_parsed": [
          {
            "location": "cerebellar hemisphere",
            "side": "right",
            "qualifier": null
          },
          {
            "location": "paracentral lobule",
            "side": "left",
            "qualifier": null
          },
          {
            "location": "optic nerve",
            "side": "left",
            "qualifier": null
          }
        ],
        "exact_matches": [
          "right cerebellum",
          "left optic nerve (cranial nerve II)"
        ],
        "imprecise_matches": [],
        "missing_lesions_from_ft": [
          "right T7 myelopathy"
        ],
        "additional_lesions_in_ft": [
          "left paracentral lobule"
        ]
      },
      "scoring": {
        "gt_lesion_count": 3,
        "correctly_identified_count": 2,
        "imprecisely_identified_count": 0,
        "missed_lesion_count": 1,
        "additional_lesion_count": 1,
        "proportion_correct": 0.6666666666666666,
        "proportion_imprecise": 0.0,
        "proportion_missed": 0.3333333333333333,
        "proportion_additional": 0.3333333333333333
      }
    },
    "Differential diagnosis": {
      "report_string": "--- Differential diagnosis ---\nCorrectly included the primary diagnosis of Multiple sclerosis.\n\n- Agree with considering other possibilities such as Neurosarcoidosis, Neuromyelitis Optica Spectrum Disorder (AQP4+), CNS Vasculitis, Multiple Sclerosis and MOG Antibody-Associated Disease.\n\n- Other differentials to consider based on the clinical presentation include: Neurosyphilis and Autoimmune Myelitis (SLE).\n\nThese suggested differentials are much less likely to explain the clinical picture than those above:\n- Vitamin B12 deficiency; Ischaemic cerebellar stroke",
      "structured_data": {
        "ft_diagnoses_raw": [
          "Relapsing-remitting multiple sclerosis",
          "Myelin oligodendrocyte glycoprotein antibody-associated disease (MOGAD)",
          "Neuromyelitis optica spectrum disorder (AQP4-IgG positive)",
          "CNS sarcoidosis",
          "Primary CNS vasculitis",
          "Vitamin B12 deficiency",
          "Ischaemic cerebellar stroke"
        ],
        "gt_diagnoses_with_source": {
          "Multiple sclerosis": "evaluation",
          "Palpitations": "comorbidity",
          "Gallstones": "comorbidity",
          "Confusional arousal": "comorbidity",
          "Group B strep": "comorbidity"
        },
        "correctly_mentioned_original_gt": [
          "Multiple sclerosis"
        ],
        "missing_original_gt": [
          "Palpitations",
          "Gallstones",
          "Confusional arousal",
          "Group B strep"
        ],
        "matched_lesion_dx_keys": [
          "Neurosarcoidosis",
          "AQP4_NMOSD",
          "CNS_Vasculitis",
          "MS",
          "MOGAD"
        ],
        "missing_lesion_dx_keys": [
          "Syphilis",
          "Autoimmune_Myelitis_SLE"
        ],
        "additional_diagnoses": [
          "Vitamin B12 deficiency",
          "Ischaemic cerebellar stroke"
        ]
      },
      "scoring": {
        "primary_diagnosis_included": 1,
        "primary_diagnosis_name": "Multiple sclerosis",
        "gt_total_count": 5,
        "gt_matched_count": 1,
        "gt_missed_count": 4,
        "gt_coverage_percentage": 0.2,
        "additional_inappropriate_count": 2,
        "comorbidity_total_count": 0,
        "comorbidity_missing_count": 0,
        "comorbidity_missing_proportion": null
      }
    },
    "Investigations": {
      "report_string": "--- Investigations ---\nAgree with all suggestions.\n\n- MRI including the Brain; Orbits, and Thoracic Spine and CSF test for Oligoclonal Bands would potentially inform a diagnosis of multiple sclerosis.\n\nTo evaluate other differential diagnoses:\n- Agree with considering: Antinuclear antibody (ANA), Serum AQP4-IgG antibodies, Extractable nuclear antigen (ENA) panel, Serum MOG-IgG antibodies, Serum ACE level, Syphilis serology (treponemal test and RPR).\n- Could also consider: Cerebral angiography.",
      "structured_data": {
        "gt_required_tests_primary": [
          {
            "type": "CSF",
            "detail": "Oligoclonal Bands",
            "condition": "Multiple sclerosis"
          },
          {
            "type": "MRI",
            "region": "Brain",
            "condition": "Multiple sclerosis"
          },
          {
            "type": "MRI",
            "region": "Orbits",
            "condition": "Multiple sclerosis"
          },
          {
            "type": "MRI",
            "region": "Thoracic Spine",
            "condition": "Multiple sclerosis"
          }
        ],
        "ft_proposed_investigations": [
          "MRI brain and orbits with gadolinium",
          "MRI cervical and thoracic spine with gadolinium",
          "Lumbar puncture with CSF analysis including cell count, protein, glucose, oligoclonal bands, and IgG index",
          "Visual evoked potentials",
          "Optical coherence tomography",
          "Full blood count",
          "Urea and electrolytes",
          "Liver function tests",
          "C-reactive protein",
          "Erythrocyte sedimentation rate",
          "Vitamin B12",
          "Serum folate",
          "Thyroid-stimulating hormone",
          "Serum vitamin D",
          "Serum ACE",
          "Antinuclear antibody",
          "Extractable nuclear antigen panel",
          "Aquaporin-4 IgG (cell-based assay)",
          "MOG-IgG (cell-based assay)",
          "HIV 1/2 antigen/antibody",
          "Hepatitis B surface antigen",
          "Hepatitis C antibody",
          "Syphilis serology",
          "Varicella zoster virus IgG",
          "QuantiFERON-TB Gold",
          "Serum or urine beta-hCG"
        ],
        "found_tests_primary": [
          {
            "type": "MRI",
            "region": "Brain",
            "condition": "Multiple sclerosis"
          },
          {
            "type": "MRI",
            "region": "Orbits",
            "condition": "Multiple sclerosis"
          },
          {
            "type": "MRI",
            "region": "Thoracic Spine",
            "condition": "Multiple sclerosis"
          },
          {
            "type": "CSF",
            "detail": "Oligoclonal Bands",
            "condition": "Multiple sclerosis"
          }
        ],
        "missing_tests_primary": [],
        "expected_inv_keys_ddx": [
          "ANA",
          "AQP4_Antibodies",
          "Cerebral_Angiography",
          "ENA_Panel",
          "MOG_Antibodies",
          "Serum_ACE",
          "Syphilis_Serology"
        ],
        "found_inv_keys_ddx": [
          "MOG_Antibodies",
          "AQP4_Antibodies",
          "Syphilis_Serology",
          "ENA_Panel",
          "Serum_ACE",
          "ANA"
        ],
        "missing_inv_keys_ddx": [
          "Cerebral_Angiography"
        ]
      },
      "scoring": {
        "primary_tests_required_count": 4,
        "primary_tests_found_count": 4,
        "primary_tests_missed_count": 0,
        "primary_tests_coverage_percentage": 1.0,
        "ddx_tests_expected_count": 7,
        "ddx_tests_found_count": 6,
        "ddx_tests_coverage_percentage": 0.8571428571428571
      }
    },
    "Management": {
      "report_string": "--- Management ---\nSteroids: Not appropriate to start treatment immediately.\n  \nAdditional factors not mentioned:\n\n- Presenting complaint not specified, so no indication whether this is a new or an old deficit.\n\nDMTs: Appropriate to consider but delay treatment.\n  \nCorrectly identified the following:\n\n- Need confirmation of MS diagnosis.\n  \nAdditional factors not mentioned:\n\n- Need a pregnancy test result.",
      "structured_data": {
        "ft_full_plan_parsed": [
          {
            "treatment": "Intravenous methylprednisolone 1 g daily for 3\u20135 days",
            "timing": "Start Now",
            "reasons": [
              "Acute disabling relapse with cerebellar ataxia and optic neuritis features",
              "Improves speed of neurological recovery",
              "Low risk once infection is excluded"
            ]
          },
          {
            "treatment": "Proton pump inhibitor for gastric protection",
            "timing": "Start Now",
            "reasons": [
              "High-dose corticosteroid therapy increases GI risk",
              "Prevention of steroid-induced dyspepsia/ulceration"
            ]
          },
          {
            "treatment": "Physiotherapy and gait/fall-prevention programme",
            "timing": "Start Now",
            "reasons": [
              "Ataxic, unsteady gait",
              "Reduces fall risk and promotes functional recovery"
            ]
          },
          {
            "treatment": "Low-molecular-weight heparin for VTE prophylaxis (unless contraindicated)",
            "timing": "Start Now",
            "reasons": [
              "Reduced mobility due to cerebellar ataxia and limb weakness",
              "Prevents deep vein thrombosis"
            ]
          },
          {
            "treatment": "Oral baclofen for spasticity",
            "timing": "Start Now",
            "reasons": [
              "Right lower-limb spasticity and clonus causing functional impairment",
              "Improves comfort and mobility"
            ]
          },
          {
            "treatment": "Plasma exchange",
            "timing": "Delay",
            "reasons": [
              "Reserve for steroid-refractory acute relapse",
              "Greatest benefit within 2 weeks if inadequate response to steroids"
            ]
          },
          {
            "treatment": "High-efficacy disease-modifying therapy for MS (e.g., ocrelizumab or natalizumab, per eligibility)",
            "timing": "Delay",
            "reasons": [
              "Initiate after confirmation of MS by MRI/CSF per McDonald criteria",
              "Requires infection screening, vaccination review, and risk stratification (e.g., JCV)"
            ]
          },
          {
            "treatment": "Vitamin D supplementation",
            "timing": "Start Now",
            "reasons": [
              "Safe and commonly deficient; deficiency is associated with MS activity",
              "Bone protection during and after corticosteroid use"
            ]
          }
        ],
        "steroids_evaluation": {
          "ft_plan": {
            "treatment": "Intravenous methylprednisolone 1 g daily for 3\u20135 days",
            "timing": "Start Now",
            "reasons": [
              "Acute disabling relapse with cerebellar ataxia and optic neuritis features",
              "Improves speed of neurological recovery",
              "Low risk once infection is excluded"
            ]
          },
          "gt_plan": {
            "treatment_inappropriate": true,
            "reasons": {
              "missing_information": [
                "Presenting complaint not specified, so no indication whether this is a new or an old deficit."
              ],
              "contraindications": []
            }
          },
          "evaluation_summary": "Not appropriate to start treatment immediately.\n  \nAdditional factors not mentioned:\n\n- Presenting complaint not specified, so no indication whether this is a new or an old deficit."
        },
        "dmt_evaluation": {
          "ft_plan": {
            "treatment": "High-efficacy disease-modifying therapy for MS (e.g., ocrelizumab or natalizumab, per eligibility)",
            "timing": "Delay",
            "reasons": [
              "Initiate after confirmation of MS by MRI/CSF per McDonald criteria",
              "Requires infection screening, vaccination review, and risk stratification (e.g., JCV)"
            ]
          },
          "gt_plan": {
            "treatment_inappropriate": true,
            "reasons": {
              "missing_information": [
                "Need confirmation of MS diagnosis.",
                "Need a pregnancy test result."
              ],
              "contraindications": []
            }
          },
          "evaluation_summary": "Appropriate to consider but delay treatment.\n  \nCorrectly identified the following:\n\n- Need confirmation of MS diagnosis.\n  \nAdditional factors not mentioned:\n\n- Need a pregnancy test result."
        }
      },
      "scoring": {
        "steroids": {
          "decision_category": "inappropriate_commission",
          "is_unsafe": 1,
          "reasons_total": 1,
          "reasons_acknowledged": 0,
          "reasons_missed": 1,
          "reasons_coverage_percentage": 0.0
        },
        "dmt": {
          "decision_category": "appropriate_caution",
          "is_unsafe": 0,
          "reasons_total": 2,
          "reasons_acknowledged": 1,
          "reasons_missed": 1,
          "reasons_coverage_percentage": 0.5
        }
      }
    }
  }
}